Recent tissue engineering-based advances for effective rAAV-mediated gene transfer in the musculoskeletal system

References

• Evans CH. Advances in regenerative orthopedics. Mayo Clin Proc 2013;88:1323-39; PMID:24182709; http://dx.doi.org/10.1016/j.mayocp.2013.04.027
   PubMed Web of Science ®Google Scholar
• Evans CH, Huard J. Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol 2015;11:234-42; PMID:25776949; http://dx.doi.org/10.1038/nrrheum.2015.28
   PubMed Web of Science ®Google Scholar
• Qazi TH, Mooney DJ, Pumberger M, Geissler S, Duda GN. Biomaterials based strategies for skeletal muscle tissue engineering: existing technologies and future trends. Biomaterials 2015;53:502-21; PMID:25890747; http://dx.doi.org/10.1016/j.biomaterials.2015.02.110
   PubMed Web of Science ®Google Scholar
• Rey-Rico A, Cucchiarini M. Controlled release strategies for rAAV-mediated gene delivery. Acta Biomater 2016;29:1-10; PMID:26472612; http://dx.doi.org/10.1016/j.actbio.2015.10.015
   PubMed Web of Science ®Google Scholar
• Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J 2009;11:671-81; PMID:19834816; http://dx.doi.org/10.1208/s12248-009-9143-y
   PubMed Web of Science ®Google Scholar
• Giacca M, Zacchigna S. Virus-mediated gene delivery for human gene therapy. J Control Release 2012;161:377-88; PMID:22516095; http://dx.doi.org/10.1016/j.jconrel.2012.04.008
   PubMed Web of Science ®Google Scholar
• Rose JA, Berns KI, Hoggan MD, Koczot FJ. Evidence for a single-stranded adenovirus-associated virus genome: formation of a DNA density hybrid on release of viral DNA. Proc Natl Acad Sci USA 1969;64:863-9; PMID:5264145; http://dx.doi.org/10.1073/pnas.64.3.863
   PubMed Web of Science ®Google Scholar
• Berns KI, Giraud C. Adenovirus and adeno-associated virus as vectors for gene therapy. Ann N Y Acad Sci 1995;772:95-104; PMID:8546417; http://dx.doi.org/10.1111/j.1749-6632.1995.tb44735.x
   PubMed Web of Science ®Google Scholar
• Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 2008;21:583-93; PMID:18854481; http://dx.doi.org/10.1128/CMR.00008-08
   PubMed Web of Science ®Google Scholar
• Smith-Arica JR, Bartlett JS. Gene therapy: recombinant adeno-associated virus vectors. Curr Cardiol Rep 2001;3:43-9; PMID:11139798; http://dx.doi.org/10.1007/s11886-001-0009-x
   PubMedGoogle Scholar
• Grieger JC, Samulski RJ. Adeno-associated virus vectorology, manufacturing, and clinical applications. Methods Enzymol 2012;507:229-54; PMID:22365777; http://dx.doi.org/10.1016/B978-0-12-386509-0.00012-0
   PubMed Web of Science ®Google Scholar
• Kotterman MA, Schaffer DV. Engineering adeno-associated viruses for clinical gene therapy. Nat Rev Genet 2014;15:445-51; PMID:24840552; http://dx.doi.org/10.1038/nrg3742
   PubMed Web of Science ®Google Scholar
• Cucchiarini M, Henrionnet C, Mainard D, Pinzano A, Madry H. New trends in articular cartilage repair. J Exp Orthop 2015;2:8-15; PMID:26914876; http://dx.doi.org/10.1186/s40634-015-0026-0
   PubMedGoogle Scholar
• Calcedo R, Vandenberghe LH, Gao G, Lin J, Wilson JM. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J Infect Dis 2009;199:381-90; PMID:19133809; http://dx.doi.org/10.1086/595830
   PubMed Web of Science ®Google Scholar
• Arai Y, Kubo T, Fushiki S, Mazda O, Nakai H, Iwaki Y, Imanishi J, Hirasawa Y. Gene delivery to human chondrocytes by an adeno-associated virus vector. J Rheumatol 2000;27:979-82; PMID:10782826
   PubMed Web of Science ®Google Scholar
• Venkatesan JK, Rey-Rico A, Schmitt G, Wezel A, Madry H, Cucchiarini M. rAAV-mediated overexpression of TGF-beta stably restructures human osteoarthritic articular cartilage in situ. J Transl Med 2013;11:211-36; PMID:24034904; http://dx.doi.org/10.1186/1479-5876-11-211
   PubMed Web of Science ®Google Scholar
• Adriaansen J, Tas SW, Klarenbeek PL, Bakker AC, Apparailly F, Firestein GS, Jorgensen C, Vervoordeldonk MJ, Tak PP. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy. Ann Rheum Dis 2005;64:1677-84; PMID:15878906; http://dx.doi.org/10.1136/ard.2004.035063
   PubMed Web of Science ®Google Scholar
• Adriaansen J, Khoury M, de Cortie CJ, Fallaux FJ, Bigey P, Scherman D, Gould DJ, Chernajovsky Y, Apparailly F, Jorgensen C, et al. Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent. Ann Rheum Dis 2007;66:1143-50; PMID:17363402; http://dx.doi.org/10.1136/ard.2006.064519
   PubMed Web of Science ®Google Scholar
• Bevaart L, Aalbers CJ, Vierboom MP, Broekstra N, Kondova I, Breedveld E, Hauck B, Wright JF, Tak PP, Vervoordeldonk MJ. Safety, biodistribution, and efficacy of an AAV-5 vector encoding human interferon-beta (ART-I02) delivered via intra-articular injection in Rhesus monkeys with collagen-induced arthritis. Hum Gene Ther Clin Dev 2015;26:103-12; PMID:26086763; http://dx.doi.org/10.1089/humc.2015.009
   PubMed Web of Science ®Google Scholar
• Zhou X, Shen L, Liu L, Wang C, Qi W, Zhao A, Wu X, Li B. Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene. Hum Vaccin Immunother 2016;12:732-9; PMID:26837862; http://dx.doi.org/10.1080/21645515.2015.1090070
   PubMed Web of Science ®Google Scholar
• Chan JM, Villarreal G, Jin WW, Stepan T, Burstein H, Wahl SM. Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product. Mol Ther 2002;6:727-36; PMID:12498769; http://dx.doi.org/10.1006/mthe.2002.0808
   PubMed Web of Science ®Google Scholar
• Apparailly F, Khoury M, Vervoordeldonk MJ, Adriaansen J, Gicquel E, Perez N, Riviere C, Louis-Plence P, Noel D, Danos O, et al. Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints. Hum Gene Ther 2005;16:426-34; PMID:15871674; http://dx.doi.org/10.1089/hum.2005.16.426
   PubMed Web of Science ®Google Scholar
• Tas SW, Adriaansen J, Hajji N, Bakker AC, Firestein GS, Vervoordeldonk MJ, Tak PP. Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5. Hum Gene Ther 2006;17:821-32; PMID:16942442; http://dx.doi.org/10.1089/hum.2006.17.821
   PubMed Web of Science ®Google Scholar
• Sun J, Hakobyan N, Valentino LA, Feldman BL, Samulski RJ, Monahan PE. Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX. Blood 2008;112:4532-41; PMID:18716130; http://dx.doi.org/10.1182/blood-2008-01-131417
   PubMed Web of Science ®Google Scholar
• Zhang T, Yu H, Gong W, Zhang L, Jia T, Wooley PH, Yang SY. The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. Biomaterials 2009;30:6102-8; PMID:19665222; http://dx.doi.org/10.1016/j.biomaterials.2009.07.032
   PubMed Web of Science ®Google Scholar
• Khoury M, Courties G, Fabre S, Bouffi C, Seemayer CA, Vervoordeldonk MJ, Tak PP, Jorgensen C, Apparailly F. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis. Arthritis Rheum 2010;62:765-70; PMID:20187132; http://dx.doi.org/10.1002/art.27302
   PubMed Web of Science ®Google Scholar
• Zhou Q, Guo R, Wood R, Boyce BF, Liang Q, Wang YJ, Schwarz EM, Xing L. Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. Arthritis Rheum 2011;63:2318-28; PMID:21538325; http://dx.doi.org/10.1002/art.30421
   PubMed Web of Science ®Google Scholar
• Shi J, Diao Z, Zhou J, Zhu J, Yuan H, You X, Liu Y, Zheng D. Epirubicin potentiates recombinant adeno-associated virus type 2/5-mediated TRAIL expression in fibroblast-like synoviocytes and augments the anti-arthritic effects of rAAV2/5-TRAIL. Arthritis Rheum 2012;64:1345-54; http://dx.doi.org/10.1002/art.33492
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang F, Wang B, Zhang J, Yu JY. Intraarticular gene delivery of CTLA4-FasL suppresses experimental arthritis. Int Immunol 2012;24:379-88; PMID:22354915; http://dx.doi.org/10.1093/intimm/dxs041
   PubMed Web of Science ®Google Scholar
• Goodrich LR, Phillips JN, McIlwraith CW, Foti SB, Grieger JC, Gray SJ, Samulski RJ. Optimization of scAAVIL-1ra in vitro and in vivo to deliver high levels of therapeutic protein for treatment of osteoarthritis. Mol Ther Nucleic Acids 2013;2:e70-9; PMID:23385523; http://dx.doi.org/10.1038/mtna.2012.61
   PubMedGoogle Scholar
• Mason JB, Gurda BL, Engiles JB, Hankenson KD, Wilson JM, Richardson DW. Multiple recombinant adeno-associated viral vector serotypes display persistent in vivo gene expression in vector-transduced rat stifle joints. Hum Gene Ther Methods 2013;24:185-94; PMID:23659250; http://dx.doi.org/10.1089/hgtb.2012.199
   PubMed Web of Science ®Google Scholar
• Payne KA, Lee HH, Haleem AM, Martins C, Yuan Z, Qiao C, Xiao X, Chu CR. Single intra-articular injection of adeno-associated virus results in stable and controllable in vivo transgene expression in normal rat knees. Osteoarthritis Cartilage 2011;19:1058-65; PMID:21571082; http://dx.doi.org/10.1016/j.joca.2011.04.009
   PubMed Web of Science ®Google Scholar
• Ghivizzani SC, Lechman ER, Kang R, Tio C, Kolls J, Evans CH, Robbins PD. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci USA 1998;95:4613-8; PMID:9539786; http://dx.doi.org/10.1073/pnas.95.8.4613
   PubMed Web of Science ®Google Scholar
• Lechman ER, Jaffurs D, Ghivizzani SC, Gambotto A, Kovesdi I, Mi Z, Evans CH, Robbins PD. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J Immunol 1999;163:2202-8; PMID:10438962
   PubMed Web of Science ®Google Scholar
• Boyle DL, Nguyen KH, Zhuang S, Shi Y, McCormack JE, Chada S, Firestein GS. Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity. Gene Ther 1999;6:1911-8; PMID:10637442; http://dx.doi.org/10.1038/sj.gt.3301049
   PubMed Web of Science ®Google Scholar
• Kim SH, Lechman ER, Kim S, Nash J, Oligino TJ, Robbins PD. Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis. Mol Ther 2002;6:591-600; PMID:12409257; http://dx.doi.org/10.1016/S1525-0016(02)90711-2
   PubMed Web of Science ®Google Scholar
• Gouze E, Pawliuk R, Gouze JN, Pilapil C, Fleet C, Palmer GD, Evans CH, Leboulch P, Ghivizzani SC. Lentiviral-mediated gene delivery to synovium: potent intra-articular expression with amplification by inflammation. Mol Ther 2003;7:460-6; PMID:12727108; http://dx.doi.org/10.1016/S1525-0016(03)00024-8
   PubMed Web of Science ®Google Scholar
• Lechman ER, Keravala A, Nash J, Kim SH, Mi Z, Robbins PD. The contralateral effect conferred by intra-articular adenovirus-mediated gene transfer of viral IL-10 is specific to the immunizing antigen. Gene Ther 2003;10:2029-35; PMID:14566362; http://dx.doi.org/10.1038/sj.gt.3302109
   PubMed Web of Science ®Google Scholar
• Cucchiarini M, Madry H, Ma C, Thurn T, Zurakowski D, Menger MD, Kohn D, Trippel SB, Terwilliger EF. Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. Mol Ther 2005;12:229-38; PMID:16043094; http://dx.doi.org/10.1016/j.ymthe.2005.03.012
   PubMed Web of Science ®Google Scholar
• Hiraide A, Yokoo N, Xin KQ, Okuda K, Mizukami H, Ozawa K, Saito T. Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector. Hum Gene Ther 2005;16:1413-21; PMID:16390272; http://dx.doi.org/10.1089/hum.2005.16.1413
   PubMed Web of Science ®Google Scholar
• Cucchiarini M, Orth P, Madry H. Direct rAAV SOX9 administration for durable articular cartilage repair with delayed terminal differentiation and hypertrophy in vivo. J Mol Med (Berl) 2013;91:625-36; PMID:23149825; http://dx.doi.org/10.1007/s00109-012-0978-9
   PubMed Web of Science ®Google Scholar
• Cucchiarini M, Madry H. Overexpression of human IGF-I via direct rAAV-mediated gene transfer improves the early repair of articular cartilage defects in vivo. Gene Ther 2014;21:811-9; PMID:24989812; http://dx.doi.org/10.1038/gt.2014.58
   PubMed Web of Science ®Google Scholar
• Calcedo R, Wilson JM. Humoral immune response to AAV. Front Immunol 2013;4:341. PMID:24151496; http://dx.doi.org/10.3389/fimmu.2013.00341
   PubMed Web of Science ®Google Scholar
• Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007;213:626-34; PMID:17786965; http://dx.doi.org/10.1002/jcp.21258
   PubMed Web of Science ®Google Scholar
• Minas T. A primer in cartilage repair. J Bone Joint Surg Br 2012;94:141-6; PMID:23118403; http://dx.doi.org/10.1302/0301-620X.94B11.30679
   PubMedGoogle Scholar
• Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889-95; PMID:8078550; http://dx.doi.org/10.1056/NEJM199410063311401
   PubMed Web of Science ®Google Scholar
• Horas U, Pelinkovic D, Herr G, Aigner T, Schnettler R. Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective, comparative trial. J Bone Joint Surg Am 2003;85-A:185-92; PMID:12571292
   PubMed Web of Science ®Google Scholar
• Knutsen G, Engebretsen L, Ludvigsen TC, Drogset JO, Grontvedt T, Solheim E, Strand T, Roberts S, Isaksen V, Johansen O. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am 2004;86-A:455-64; PMID:14996869
   PubMed Web of Science ®Google Scholar
• Johnstone B, Alini M, Cucchiarini M, Dodge GR, Eglin D, Guilak F, Madry H, Mata A, Mauck RL, Semino CE, et al. Tissue engineering for articular cartilage repair–the state of the art. Eur Cell Mater 2013;25:248-67; PMID:23636950
   PubMed Web of Science ®Google Scholar
• Lee HH, Haleem AM, Yao V, Li J, Xiao X, Chu CR. Release of bioactive adeno-associated virus from fibrin scaffolds: effects of fibrin glue concentrations. Tissue Eng Part A 2011;17:1969-78; PMID:21449684; http://dx.doi.org/10.1089/ten.tea.2010.0586
   PubMed Web of Science ®Google Scholar
• Rey-Rico A, Venkatesan JK, Frisch J, Schmitt G, Monge-Marcet A, Lopez-Chicon P, Mata A, Semino C, Madry H, Cucchiarini M. Effective and durable genetic modification of human mesenchymal stem cells via controlled release of rAAV vectors from self-assembling peptide hydrogels with a maintained differentiation potency. Acta Biomater 2015;18:118-27; PMID:25712390; http://dx.doi.org/10.1016/j.actbio.2015.02.013
   PubMed Web of Science ®Google Scholar
• Rey-Rico A, Venkatesan JK, Frisch J, Rial-Hermida I, Schmitt G, Concheiro A, Madry H, Alvarez-Lorenzo C, Cucchiarini M. PEO-PPO-PEO micelles as effective rAAV-mediated gene delivery systems to target human mesenchymal stem cells without altering their differentiation potency. Acta Biomater 2015;27:42-52; PMID:26320543; http://dx.doi.org/10.1016/j.actbio.2015.08.046
   PubMed Web of Science ®Google Scholar
• Diaz-Rodriguez P, Rey-Rico A, Madry H, Landin M, Cucchiarini M. Effective genetic modification and differentiation of hMSCs upon controlled release of rAAV vectors using alginate/poloxamer composite systems. Int J Pharm 2015;496:614-26; PMID:26556623; http://dx.doi.org/10.1016/j.ijpharm.2015.11.008
   PubMed Web of Science ®Google Scholar
• Alvarez-Lorenzo C, Sosnik A, Concheiro A. PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy. Curr Drug Targets 2011;12:1112-30; PMID:21443477; http://dx.doi.org/10.2174/138945011795906615
   PubMed Web of Science ®Google Scholar
• Cottard V, Valvason C, Falgarone G, Lutomski D, Boissier MC, Bessis N. Immune response against gene therapy vectors: influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes. J Clin Immunol 2004;24:162-9; PMID:15024183; http://dx.doi.org/10.1023/B:JOCI.0000019781.64421.5c
   PubMed Web of Science ®Google Scholar
• Rey-Rico A, Frisch J, Venkatesan JK, Schmitt G, Madry H, Cucchiarini M. Determination of effective rAAV-mediated gene transfer conditions to support chondrogenic differentiation processes in human primary bone marrow aspirates. Gene Ther 2015;22:50-7; PMID:25338919; http://dx.doi.org/10.1038/gt.2014.90
   PubMed Web of Science ®Google Scholar
• Pascher A, Palmer GD, Steinert A, Oligino T, Gouze E, Gouze JN, Betz O, Spector M, Robbins PD, Evans CH, et al. Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther 2004;11:133-41; PMID:14712297; http://dx.doi.org/10.1038/sj.gt.3302155
   PubMed Web of Science ®Google Scholar
• Frisch J, Venkatesan JK, Rey-Rico A, Schmitt G, Madry H, Cucchiarini M. Determination of the chondrogenic differentiation processes in human bone marrow-derived mesenchymal stem cells genetically modified to overexpress transforming growth factor-beta via recombinant adeno-associated viral vectors. Hum Gene Ther 2014;25:1050-60; PMID:25333854; http://dx.doi.org/10.1089/hum.2014.091
   PubMed Web of Science ®Google Scholar
• Frisch J, Rey-Rico A, Venkatesan JK, Schmitt G, Madry H, Cucchiarini M. Chondrogenic differentiation processes in human bone marrow aspirates upon rAAV-mediated gene transfer and overexpression of the insulin-like growth factor I. Tissue Eng Part A 2015;21:2460-71; PMID:26123891; http://dx.doi.org/10.1089/ten.tea.2014.0679
   PubMed Web of Science ®Google Scholar
• Frisch J, Rey-Rico A, Venkatesan JK, Schmitt G, Madry H, Cucchiarini M. rAAV-mediated overexpression of sox9, TGF-beta and IGF-I in minipig bone marrow aspirates to enhance the chondrogenic processes for cartilage repair. Gene Ther 2016;23:247-55; PMID:26583804; http://dx.doi.org/10.1038/gt.2015.106
   PubMed Web of Science ®Google Scholar
• Frisch J, Rey-Rico A, Venkatesan JK, Schmitt G, Madry H, Cucchiarini M. TGF-beta gene transfer and overexpression via rAAV vectors stimulates chondrogenic events in human bone marrow aspirates. J Cell Mol Med 2016;20:430-40; PMID:26808466; http://dx.doi.org/10.1111/jcmm.12774
   PubMed Web of Science ®Google Scholar
• Basad E, Ishaque B, Bachmann G, Sturz H, Steinmeyer J. Matrix-induced autologous chondrocyte implantation versus microfracture in the treatment of cartilage defects of the knee: a 2-year randomised study. Knee Surg Sports Traumatol Arthrosc 2010;18:519-27; PMID:20062969; http://dx.doi.org/10.1007/s00167-009-1028-1
   PubMed Web of Science ®Google Scholar
• Ortved KF, Begum L, Mohammed HO, Nixon AJ. Implantation of rAAV5-IGF-I transduced autologous chondrocytes improves cartilage repair in full-thickness defects in the equine model. Mol Ther 2015;23:363-73; PMID:25311491; http://dx.doi.org/10.1038/mt.2014.198
   PubMed Web of Science ®Google Scholar
• Gelse K, Muhle C, Franke O, Park J, Jehle M, Durst K, Goken M, Hennig F, von der Mark K, Schneider H. Cell-based resurfacing of large cartilage defects: long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis. Arthritis Rheum 2008;58:475-88; PMID:18240212; http://dx.doi.org/10.1002/art.23124
   PubMed Web of Science ®Google Scholar
• Gelse K, Muhle C, Knaup K, Swoboda B, Wiesener M, Hennig F, Olk A, Schneider H. Chondrogenic differentiation of growth factor-stimulated precursor cells in cartilage repair tissue is associated with increased HIF-1alpha activity. Osteoarthritis Cartilage 2008;16:1457-65; PMID:18524637; http://dx.doi.org/10.1016/j.joca.2008.04.006
   PubMed Web of Science ®Google Scholar
• Balmayor ER, van Griensven M. Gene therapy for bone engineering. Front Bioeng Biotechnol 2015;3:9-15; PMID:25699253; http://dx.doi.org/10.3389/fbioe.2015.00009
   PubMedGoogle Scholar
• Epstein NE. Iliac crest autograft versus alternative constructs for anterior cervical spine surgery: Pros, cons, and costs. Surg Neurol Int 2012;3:S143-56; PMID:22905321; http://dx.doi.org/10.4103/2152-7806.98575
   PubMedGoogle Scholar
• Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-5; PMID:2809818; http://dx.doi.org/10.1097/00005131-198909000-00002
   PubMedGoogle Scholar
• Ito H, Koefoed M, Tiyapatanaputi P, Gromov K, Goater JJ, Carmouche J, Zhang X, Rubery PT, Rabinowitz J, Samulski RJ, et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 2005;11:291-7; PMID:15711561; http://dx.doi.org/10.1038/nm1190
   PubMed Web of Science ®Google Scholar
• Koefoed M, Ito H, Gromov K, Reynolds DG, Awad HA, Rubery PT, Ulrich-Vinther M, Soballe K, Guldberg RE, Lin AS, et al. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther 2005;12:212-8; PMID:16043092; http://dx.doi.org/10.1016/j.ymthe.2005.02.026
   PubMed Web of Science ®Google Scholar
• Yazici C, Takahata M, Reynolds DG, Xie C, Samulski RJ, Samulski J, Beecham EJ, Gertzman AA, Spilker M, Zhang X, et al. Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur. Mol Ther 2011;19:1416-25; PMID:21206485; http://dx.doi.org/10.1038/mt.2010.294
   PubMed Web of Science ®Google Scholar
• Ben Arav A, Pelled G, Zilberman Y, Kimelman-Bleich N, Gazit Z, Schwarz EM, Gazit D. Adeno-associated virus-coated allografts: a novel approach for cranioplasty. J Tissue Eng Regen Med 2012;6:e43-50; PMID:22941779; http://dx.doi.org/10.1002/term.1594
   PubMedGoogle Scholar
• Yazici C, Yanoso L, Xie C, Reynolds DG, Samulski RJ, Samulski J, Yannariello-Brown J, Gertzman AA, Zhang X, Awad HA, et al. The effect of surface demineralization of cortical bone allograft on the properties of recombinant adeno-associated virus coatings. Biomaterials 2008;29:3882-7; PMID:18590929; http://dx.doi.org/10.1016/j.biomaterials.2008.06.007
   PubMed Web of Science ®Google Scholar
• Nasu T, Ito H, Tsutsumi R, Kitaori T, Takemoto M, Schwarz EM, Nakamura T. Biological activation of bone-related biomaterials by recombinant adeno-associated virus vector. J Orthop Res 2009;27:1162-8; PMID:19242999; http://dx.doi.org/10.1002/jor.20860
   PubMed Web of Science ®Google Scholar
• Dupont KM, Boerckel JD, Stevens HY, Diab T, Kolambkar YM, Takahata M, Schwarz EM, Guldberg RE. Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair. Cell Tissue Res 2012;347:575-88; PMID:21695398; http://dx.doi.org/10.1007/s00441-011-1197-3
   PubMed Web of Science ®Google Scholar
• Aslan H, Kimelman-Bleich N, Pelled G, Gazit D. Molecular targets for tendon neoformation. J Clin Invest 2008;118:439-44; PMID:18246194; http://dx.doi.org/10.1172/JCI33944
   PubMed Web of Science ®Google Scholar
• Benjamin M, Kaiser E, Milz S. Structure-function relationships in tendons: a review. J Anat 2008;212:211-28; PMID:18304204; http://dx.doi.org/10.1111/j.1469-7580.2008.00864.x
   PubMed Web of Science ®Google Scholar
• Nixon AJ, Watts AE, Schnabel LV. Cell- and gene-based approaches to tendon regeneration. J Shoulder Elbow Surg 2012;21:278-94; PMID:22244071; http://dx.doi.org/10.1016/j.jse.2011.11.015
   PubMed Web of Science ®Google Scholar
• Docheva D, Muller SA, Majewski M, Evans CH. Biologics for tendon repair. Adv Drug Deliv Rev 2015;84:222-39; PMID:25446135; http://dx.doi.org/10.1016/j.addr.2014.11.015
   PubMed Web of Science ®Google Scholar
• Wang XT, Liu PY, Tang JB, Mizukami H, Xin KQ, Ozawa K, Ushijima H. Tendon healing in vitro: adeno-associated virus-2 effectively transduces intrasynovial tenocytes with persistent expression of the transgene, but other serotypes do not. Plast Reconstr Surg 2007;119:227-34; PMID:17255678; http://dx.doi.org/10.1097/01.prs.0000244861.57040.3f
   PubMed Web of Science ®Google Scholar
• Wu YF, Mao WF, Zhou YL, Wang XT, Liu PY, Tang JB. Adeno-associated virus-2-mediated TGF-beta1 microRNA transfection inhibits adhesion formation after digital flexor tendon injury. Gene Ther 2016;23:167-75; PMID:26381218; http://dx.doi.org/10.1038/gt.2015.97
   PubMed Web of Science ®Google Scholar
• Zhu B, Cao Y, Xin KQ, Wang XT, Summerhayes IC, Liu PY, Tang JB. Tissue reactions of adenoviral, adeno-associated viral, and liposome-plasmid vectors in tendons and comparison with early-stage healing responses of injured flexor tendons. J Hand Surg Am 2006;31:1652-60; PMID:17145387; http://dx.doi.org/10.1016/j.jhsa.2006.09.007
   PubMed Web of Science ®Google Scholar
• Basile P, Dadali T, Jacobson J, Hasslund S, Ulrich-Vinther M, Soballe K, Nishio Y, Drissi MH, Langstein HN, Mitten DJ, et al. Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery. Mol Ther 2008;16:466-73; PMID:18180771; http://dx.doi.org/10.1038/sj.mt.6300395
   PubMed Web of Science ®Google Scholar
• Hasslund S, Dadali T, Ulrich-Vinther M, Soballe K, Schwarz EM, Awad HA. Freeze-dried allograft-mediated gene or protein delivery of growth and differentiation factor 5 reduces reconstructed murine flexor tendon adhesions. J Tissue Eng 2014;5:2041731414528736-43; PMID:24812579; http://dx.doi.org/10.1177/2041731414528736
   PubMedGoogle Scholar
• Wang D, Zhong L, Nahid MA, Gao G. The potential of adeno-associated viral vectors for gene delivery to muscle tissue. Expert Opin Drug Deliv 2014;11:345-64; PMID:24386892; http://dx.doi.org/10.1517/17425247.2014.871258
   PubMed Web of Science ®Google Scholar
• Block TA, Aarsvold JN, Matthews KL 2nd, Mintzer RA, River LP, Capelli-Schellpfeffer M, Wollmann RL, Tripathi S, Chen CT, Lee RC. The 1995 Lindberg Award. Nonthermally mediated muscle injury and necrosis in electrical trauma. J Burn Care Rehabil 1995;16:581-8; PMID:8582934; http://dx.doi.org/10.1097/00004630-199511000-00004
   PubMedGoogle Scholar
• Djurovic S, Iversen N, Jeansson S, Hoover F, Christensen G. Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes. Mol Biotechnol 2004;28:21-32; PMID:15456960; http://dx.doi.org/10.1385/MB:28:1:21
   PubMed Web of Science ®Google Scholar
• High KA. The gene therapy journey for hemophilia: are we there yet? Blood 2012;120:4482-7; PMID:22829631; http://dx.doi.org/10.1182/blood-2012-05-423210
   PubMed Web of Science ®Google Scholar
• Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR, Tai SJ, Ragni MV, Thompson A, Ozelo M, et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003;101:2963-72; PMID:12515715; http://dx.doi.org/10.1182/blood-2002-10-3296
   PubMed Web of Science ®Google Scholar
• Lee GK, Maheshri N, Kaspar B, Schaffer DV. PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. Biotechnol Bioeng 2005;92:24-34; PMID:15937953; http://dx.doi.org/10.1002/bit.20562
   PubMed Web of Science ®Google Scholar
• Le HT, Yu QC, Wilson JM, Croyle MA. Utility of PEGylated recombinant adeno-associated viruses for gene transfer. J Control Release 2005;108:161-77; PMID:16125817; http://dx.doi.org/10.1016/j.jconrel.2005.07.019
   PubMed Web of Science ®Google Scholar
• Moulay G, Boutin S, Masurier C, Scherman D, Kichler A. Polymers for improving the in vivo transduction efficiency of AAV2 vectors. PLoS One 2010;5:e15576-83; PMID:21203395; http://dx.doi.org/10.1371/journal.pone.0015576
   PubMedGoogle Scholar